0 CHECKOUT

Heart Transplantation - Pipeline Review, H1 2015

  • ID: 3231012
  • April 2015
  • 32 pages
  • Global Markets Direct
1 of 4

FEATURED COMPANIES

  • Astellas Pharma Inc.
  • Merck & Co., Inc.
  • Viron Therapeutics, Inc.
  • MORE

Heart Transplantation - Pipeline Review, H1 2015

Summary

This, ‘Heart Transplantation - Pipeline Review, H1 2015’, provides an overview of the Heart Transplantation’s therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Heart Transplantation, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Heart Transplantation and special features on late-stage and discontinued projects.

This report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from This proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by This team. Drug profiles/records featured in the report undergoes periodic updation READ MORE >

Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Astellas Pharma Inc.
  • Merck & Co., Inc.
  • Viron Therapeutics, Inc.
  • MORE

List of Tables
List of Figures
Introduction
REPORT COVERAGE
Heart Transplantation Overview
Therapeutics Development
Pipeline Products for Heart Transplantation - Overview
Pipeline Products for Heart Transplantation - Comparative Analysis
Heart Transplantation - Therapeutics under Development by Companies
Heart Transplantation - Therapeutics under Investigation by Universities/Institutes
Heart Transplantation - Pipeline Products Glance
Early Stage Products
Heart Transplantation - Products under Development by Companies
Heart Transplantation - Products under Investigation by Universities/Institutes
Heart Transplantation - Companies Involved in Therapeutics Development
Astellas Pharma Inc.
Merck & Co., Inc.
Viron Therapeutics, Inc.
Heart Transplantation - Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Target
Assessment by Mechanism of Action
Assessment by Molecule Type
Drug Profiles
AS-2521780 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
SCH-546738 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Small Molecules to Inhibit C-Rel for Central Nervous System, Immunology, Musculoskeletal, Oncology, Respiratory and Metabolic Disorders - Drug Profile
Product Description
Mechanism of Action
R&D Progress
VT-111a - Drug Profile
Product Description
Mechanism of Action
R&D Progress
VT-214 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Heart Transplantation - Recent Pipeline Updates
Heart Transplantation - Dormant Projects
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Number of Products under Development for Heart Transplantation, H1 2015
Number of Products under Development for Heart Transplantation - Comparative Analysis, H1 2015
Number of Products under Development by Companies, H1 2015
Number of Products under Investigation by Universities/Institutes, H1 2015
Comparative Analysis by Early Stage Development, H1 2015
Products under Development by Companies, H1 2015
Products under Investigation by Universities/Institutes, H1 2015
Heart Transplantation - Pipeline by Astellas Pharma Inc., H1 2015
Heart Transplantation - Pipeline by Merck & Co., Inc., H1 2015
Heart Transplantation - Pipeline by Viron Therapeutics, Inc., H1 2015
Assessment by Monotherapy Products, H1 2015
Number of Products by Stage and Target, H1 2015
Number of Products by Stage and Mechanism of Action, H1 2015
Number of Products by Stage and Molecule Type, H1 2015
Heart Transplantation Therapeutics - Recent Pipeline Updates, H1 2015
Heart Transplantation - Dormant Projects, H1 2015

List of Figures
Number of Products under Development for Heart Transplantation - Comparative Analysis, H1 2015
Comparative Analysis by Early Stage Products, H1 2015
Number of Products by Top 10 Targets, H1 2015
Number of Products by Stage and Top 10 Targets, H1 2015
Number of Products by Top 10 Mechanism of Actions, H1 2015
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2015
Number of Products by Top 10 Molecule Types, H1 2015

Note: Product cover images may vary from those shown
3 of 4

Astellas Pharma Inc.
Merck & Co., Inc.
Viron Therapeutics, Inc.

Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a site license, allowing all users within a given geographical location of your organisation access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is an enterprise license, allowing all employees within your organisation access to the product.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS from Db

Our Clients

  • Cytori Therapeutics, Inc.
  • Pfizer Inc.
  • Medtronic, Inc.
  • St. Jude Medical, Inc.
  • Novo Nordisk A/S
  • Lumedx